HPV Vaccination: Increase Uptake Now to Reduce Cancer

Affiliations

Editorial

Stephen E Hawes. Am J Public Health. 2018 Jan.

. 2018 Jan;108(1):23-24.

doi: 10.2105/AJPH.2017.304184.

¹ Stephen E. Hawes is with the Departments of Epidemiology, Global Health, and Health Services, School of Public Health, University of Washington, Seattle.

No abstract available

Comment on

Declines in Anogenital Warts Among Age Groups Most Likely to Be Impacted by Human Papillomavirus Vaccination, United States, 2006-2014.
Flagg EW, Torrone EA. Flagg EW, et al. Am J Public Health. 2018 Jan;108(1):112-119. doi: 10.2105/AJPH.2017.304119. Epub 2017 Nov 21. Am J Public Health. 2018. PMID: 29161070 Free PMC article.

1. Garland SM, Kjaer SK, Muñoz N et al. Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience. Clin Infect Dis. 2016;63(4):519–527. - PMC - PubMed
1. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609–e616. - PubMed
1. Walker TY, Elam-Evans LD, Singleton JA et al. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016. MMWR Morb Mortal Wkly Rep. 2017;66(33):874–882. - PMC - PubMed
1. Fowler CI, Saraiya M, Moskosky SB, Miller JW, Gable J, Mautone-Smith N. Trends in cervical cancer screening in Title X–funded health centers—United States, 2005–2015. MMWR Morb Mortal Wkly Rep. 2017;66(37):981–985. - PMC - PubMed
1. Bruni L, Diaz M, Barrionuevo-Rosas L et al. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. Lancet Glob Health. 2016;4(7):e453–e463. - PubMed